NMC Royal Hospital DIP Pioneers Radiation-Free Breast Cancer Surgery in UAE with Groundbreaking Sentimag Technology
Lifestyle
Revolutionizing breast cancer care, the innovative Sentimag system eliminates radioactive tracers with a safer magnetic alternative for precise lymph node detection
Published: Wed 11 Jun 2026, 11:09 AM
Dubai's healthcare landscape has reached new heights as NMC Royal Hospital DIP becomes the first facility in the UAE to perform breast cancer surgery using the revolutionary Sentimag system. This state-of-the-art technology marks a quantum leap in surgical precision while completely eliminating radiation exposure for patients undergoing sentinel lymph node procedures.
The landmark procedure was successfully conducted by Dr. Afaf Sahraoui, an internationally certified specialist in breast, thyroid and parathyroid surgery at the hospital's advanced Breast Cancer Clinic. The breakthrough represents not just a first for NMC Healthcare network but sets a new standard for oncological care across the region.
The conventional approach to sentinel lymph node biopsy - a critical diagnostic step in breast cancer treatment - has long relied on radioactive isotopes and blue dye injections. While effective, these methods carry inherent risks including radiation exposure potential allergic reactions and complex logistical coordination due to strict timing requirements.
"This is truly transformative technology," explained Dr. Sahraoui during our exclusive interview. "By replacing radioactive materials with magnetic nanoparticles we're achieving superior precision while making procedures significantly safer and more comfortable for our patients."
The cutting-edge system utilizes Magtrace®, an innovative magnetic nanoparticle solution injected prior to surgery A specialized handheld probe then detects these particles allowing surgeons to precisely locate and remove sentinel nodes without any radiation exposure For non-palpable tumors (those undetectable by touch) doctors can alternatively use Magseed® - a tiny magnetic marker that replaces traditional guidewires.
The inaugural case involved a 47-year-old patient diagnosed with invasive breast carcinoma After thorough evaluation by multidisciplinary tumor board specialists recommended lumpectomy (breast-conserving surgery) combined with sentinel node biopsy using this novel approach Since her tumor was palpable only Magtrace was required enabling successful completion through minimal incisions Remarkably she experienced virtually no discomfort discharged within six hours post-surgery showed excellent recovery at follow-up examination
"What makes this particularly groundbreaking is its accessibility," noted consultant radiologist Dr Shaista Meraj "Many facilities lack radioisotope capabilities which previously limited treatment options Now we can offer world-class diagnostics regardless of nuclear medicine infrastructure while maintaining exceptional accuracy standards"
Beyond immediate clinical benefits adoption positions Dubai as regional leader medical innovation reinforces commitment patient-centric care The hospital plans expand applications potentially benefiting thousands annually across Middle East
NMC Healthcare CEO commented "This achievement reflects relentless pursuit excellence integrating latest technologies elevate standards Our investment cutting-edge solutions like demonstrates unwavering dedication transforming lives through medicine"
The successful implementation follows extensive training rigorous testing ensures optimal outcomes As awareness grows expected become gold standard revolutionizing how approach early-stage management
